Delaware 150th General Assembly (2019-2020) Status: In Committee Bipartisan · 5 D · 1 R cosponsors

HB 268 — AN ACT TO AMEND TITLE 18, TITLE 29, AND TITLE 31 OF THE DELAWARE CODE RELATING TO INSURANCE COVERAGE OF EPINEPHRINE AUTOINJECTORS.

Last action — Reported Out of Committee (Health & Human Development) in House with 4 Favorable, 3 On Its Merits

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 150th General Assembly (2019-2020). It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

This Act requires that individual, group, State employee, and public assistance insurance plans provide coverage for epinephrine autoinjectors for individuals who are 18 years of age or under and must include at least 1 formulation of epinephrine autoinjectors on the lowest tier of the drug formulary developed and maintained by the carrier if the insurance plan has tiers.

Bill Text

Action History

  1. Reported Out of Committee (Health & Human Development) in House with 4 Favorable, 3 On Its Merits

  2. Assigned to Health & Human Development Committee in House

  3. Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

5 sponsors · 16 co-sponsors · 41 not signed on

Sponsors (5)

Not signed on (41)

41 members have not signed on to this bill.

Show all 41 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 268 do?
This Act requires that individual, group, State employee, and public assistance insurance plans provide coverage for epinephrine autoinjectors for individuals who are 18 years of age or under and must include at least 1 formulation of epinephrine autoinjectors on the lowest tier of the drug formulary developed and maintained by the carrier if the insurance plan has tiers.
Who sponsors HB 268?
HB 268 is sponsored by Michael F. Smith (Republican), Melissa Minor-Brown (Democratic), Sean M. Lynn (Democratic), Kendra Johnson (Democratic), Trey Paradee, John "Jack" Walsh, David P. Sokola (Democratic), Kimberly Williams (Democratic), Earl G. Jaques Jr., John A. Kowalko, Anthony Delcollo, Andria L. Bennett, Catherine Cloutier, Bruce C. Ennis, Paul S. Baumbach, David Bentz, Sherry Dorsey Walker, Sean Matthews, John L. Mitchell, Michael Ramone, and John J. Viola.
What is the current status of HB 268?
This bill died with 150th General Assembly (2019-2020). It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 268?
Track HB 268 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 268

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HB 268

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →